Keith Rosenbloom buys $190k in American Vanguard shares By Investing.com

Keith Rosenbloom, through his investment firm Cruiser Capital Advisors, LLC, has made a notable purchase of shares in American Vanguard Corp (NYSE:), a company specializing in agricultural chemicals. On August 28, 2024, Rosenbloom acquired 33,555 shares at a price of $5.66 each, totaling approximately $190,000.

This transaction has increased Rosenbloom’s indirect ownership stake in the company to 1,047,410 shares. The shares are held by various investment funds and separately managed accounts under Cruiser Capital’s management, where Rosenbloom serves as the Managing Member. It’s important to note that both Cruiser Capital and Mr. Rosenbloom disclaim beneficial ownership of these shares, except to the extent of their pecuniary interest, as detailed in the footnotes of the SEC filing.

Investors often monitor such purchases by insiders and investment firms as they can provide insights into the confidence levels of those who have intimate knowledge of the company. The reported transaction suggests a bullish stance by Rosenbloom on American Vanguard’s value and prospects.

American Vanguard, based in Newport Beach, California, has been a player in the agricultural sector for many years, providing a range of products and services aimed at improving crop yields and quality.

The purchase by Rosenbloom comes at a time when the agricultural chemicals industry continues to face various challenges and opportunities, with innovation and environmental considerations playing key roles in shaping the sector’s future. American Vanguard’s performance and strategic decisions in this context will be closely watched by investors and industry analysts alike.

For those interested in following the company’s insider transactions, details can be found in the public filings with the Securities and Exchange Commission.

In other recent news, American Vanguard Corporation has undergone significant changes in its executive leadership. Eric G. Wintemute has stepped down as CEO, although he will continue to serve as Chairman of the Board. The company has established an Office of CEO (OCEO), which includes CFO David Johnson, SVPHR Shirin Khosravi, CIO/General Counsel Timothy Donnelly, and board member Mark Bassett, Ph.D. The OCEO is tasked with enhancing strategy execution and accelerating a company-wide transformation focused on data systems and market participation strategies.

Additionally, American Vanguard reported a robust increase in its financial performance for the first quarter of 2024, with a 35% rise in adjusted EBITDA and an 87% boost in operating income. This growth was attributed to strong sales across all business segments. Despite a temporary suspension of its herbicide product, Dacthal, for a US EPA review, the company maintains a positive outlook.

Another recent development is the impending retirement of Executive Vice President & Chief Operating Officer, Bob Trogele, effective May 31, 2024. Trogele, who significantly contributed to AMVAC’s global reach and product offerings, will conclude a 35-year career in the agrochemical industry. American Vanguard is actively investing in digital and business transformation initiatives, with sales projected to grow between 6% and 9% in 2024 and adjusted EBITDA expected to be between $60 million and $70 million.

InvestingPro Insights

In light of Keith Rosenbloom’s recent investment in American Vanguard Corp (NYSE:AVD), it’s valuable to consider some key financial metrics and InvestingPro Tips that shed light on the company’s current standing. With a market capitalization of approximately $164.36 million, American Vanguard operates in a highly specialized sector where financial health is crucial for sustainability and growth.

One of the InvestingPro Tips highlights that management has been aggressively buying back shares, which is often a sign of confidence in the company’s future and perceived undervaluation. This aligns with Rosenbloom’s own purchase and could indicate a broader insider belief in the company’s potential. Additionally, American Vanguard has raised its dividend for 3 consecutive years, suggesting a commitment to returning value to shareholders even amidst industry challenges.

From a financial data perspective, American Vanguard’s P/E Ratio stands at -44.92, reflecting investor concerns about profitability. However, analysts predict that the company will turn profitable this year, which could be a pivotal point for investor sentiment. The company’s revenue over the last twelve months as of Q2 2024 was $585.05 million, with a gross profit margin of 30.41%, showing the company’s ability to maintain a healthy profit on its products. Despite a slight decline in revenue growth of -3.45% in Q2 2024, the consistent dividend payments, which have been maintained for 29 consecutive years, offer some reassurance about the company’s financial management.

For those considering an investment in American Vanguard, additional insights and tips are available on InvestingPro, with a total of 13 more InvestingPro Tips currently listed for AVD at https://www.investing.com/pro/AVD, providing a comprehensive analysis for prospective investors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.